Vicarious Surgical Inc. (RBOT)
| Market Cap | 3.92M -88.0% |
| Revenue (ttm) | n/a |
| Net Income | -42.12M |
| EPS | -6.55 |
| Shares Out | 7.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,889 |
| Average Volume | 38,724 |
| Open | 0.5200 |
| Previous Close | 0.4900 |
| Day's Range | 0.4800 - 0.6500 |
| 52-Week Range | 0.2700 - 13.7460 |
| Beta | 1.50 |
| RSI | 44.15 |
| Earnings Date | May 11, 2026 |
About Vicarious Surgical
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts. [Read more]
Financial Performance
Financial StatementsNews
Vicarious Surgical Reports First Quarter 2026 Financial Results
WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives...
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
WALTHAM, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”),...
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
WALTHAM, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”),...
Vicarious Surgical announces plan to pursue Nasdaq listing
Vicarious Surgical (RBOT) announced a series of strategic actions to support a potential relisting of its common stock on a national exchange. The company said, “Over the past several months,
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (OTCID: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery, today announced a series of strat...
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCID: RBOT), a next-generation robotics technology company seeking to improve lives by transforming r...
Vicarious Surgical receives delisting notice from NYSE
Vicarious Surgical (RBOT) announced that it received a notice from the NYSE that the NYSE has commenced the process of delisting the company’s Class A common stock, par value $0.0001
Vicarious Surgical Receives Delisting Notice From NYSE
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to begin delisting procedures against Vicarious Surgical
The New York Stock Exchange announced that it will commence delisting procedures against Vicarious Surgical (RBOT).
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common st...
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announce...
Vicarious Surgical announces software partnership to streamline operations
Vicarious Surgical (RBOT) announced that it has entered into a strategic partnership agreement with a global digital engineering and software development services firm. Under the agreement, the extern...
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warran...
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical files $100M mixed securities shelf
16:37 EST Vicarious Surgical (RBOT) files $100M mixed securities shelf
Vicarious Surgical Transcript: Piper Sandler 37th Annual Healthcare Conference
Management announced a $5 million reduction in 2025 cash burn guidance and plans to provide 2026 guidance before year-end. The company is focused on developing a production-equivalent robotic system, targeting design freeze by end of 2025 and first-in-human trials in 2027. Increased transparency and operational discipline are central to the new strategy.
Vicarious Surgical raises FY25 cash burn view to $45M from $50M
Vicarious Surgical (RBOT) announced an update to full-year 2025 financial guidance. Vicarious Surgical now expects full-year 2025 cash burn of approximately $45M, representing a $5M improvement from i...
Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical files to sell 2.3M shares of Class A common stock for holders
06:04 EST Vicarious Surgical (RBOT) files to sell 2.3M shares of Class A common stock for holders
Vicarious Surgical reports Q3 adjusted EPS ($1.91), consensus ($2.33)
“Since stepping into this role three months ago, my focus has been on sharpening our execution and capital discipline strategies,” said Stephen From, Chief Executive Officer. “We’ve made important pro...
Vicarious Surgical backs FY25 cash burn view of roughly $50M
16:26 EST Vicarious Surgical (RBOT) backs FY25 cash burn view of roughly $50M
Vicarious Surgical Earnings Call Transcript: Q3 2025
Q3 2025 saw a 35% year-over-year reduction in operating expenses and improved net loss per share, driven by cost-cutting and outsourcing initiatives. The design freeze milestone remains targeted for year-end 2026, with ongoing efforts to reduce cash burn and maintain strong hospital partnerships.
Vicarious Surgical Reports Third Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...